Primex Pharmaceuticals Appoints Bareket Gelbhart as Head of Business Development

15 December 2025

Zug, Switzerland. Swiss pharmaceutical company Primex Pharmaceuticals AG announces the appointment of Bareket Gelbhart as Head of Business Development.

Ms Gelbhart brings 30 years of experience in the pharmaceutical industry to Primex Pharmaceuticals with expertise in establishing and fostering valuable strategic and product-related partnerships. She possesses significant leadership skills in business development and licensing, most recently serving as Director of Global Business Development & Licensing and B2B Sales at Sintetica. 

Ms Gelbhart will spearhead Primex’s partnering efforts and can be reached at bd@primexpharma.com.